- Home
- UHG vs RNAC Comparison
UHG vs RNAC Comparison
Compare UHG & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHG
- RNAC
- Stock Information
- Founded
- UHG 2004
- RNAC 2007
- Country
- UHG United States
- RNAC United States
- Employees
- UHG N/A
- RNAC N/A
- Industry
- UHG Homebuilding
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- UHG Consumer Discretionary
- RNAC Health Care
- Exchange
- UHG Nasdaq
- RNAC Nasdaq
- Market Cap
- UHG 248.7M
- RNAC 276.3M
- IPO Year
- UHG N/A
- RNAC 2016
- Fundamental
- Price
- UHG $2.00
- RNAC $9.67
- Analyst Decision
- UHG
- RNAC Strong Buy
- Analyst Count
- UHG 0
- RNAC 4
- Target Price
- UHG N/A
- RNAC $40.00
- AVG Volume (30 Days)
- UHG 111.3K
- RNAC 81.3K
- Earning Date
- UHG 11-06-2025
- RNAC 11-06-2025
- Dividend Yield
- UHG N/A
- RNAC N/A
- EPS Growth
- UHG N/A
- RNAC N/A
- EPS
- UHG 0.10
- RNAC N/A
- Revenue
- UHG $445,963,017.00
- RNAC $1,026,000.00
- Revenue This Year
- UHG N/A
- RNAC N/A
- Revenue Next Year
- UHG N/A
- RNAC N/A
- P/E Ratio
- UHG $44.59
- RNAC N/A
- Revenue Growth
- UHG 7.51
- RNAC N/A
- 52 Week Low
- UHG $1.60
- RNAC $8.46
- 52 Week High
- UHG $6.93
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- UHG 21.11
- RNAC 47.80
- Support Level
- UHG $3.91
- RNAC $8.95
- Resistance Level
- UHG $4.78
- RNAC $10.12
- Average True Range (ATR)
- UHG 0.24
- RNAC 0.54
- MACD
- UHG -0.12
- RNAC -0.02
- Stochastic Oscillator
- UHG 2.38
- RNAC 48.04
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.